We are live on
!
Find out more
Stocks With The Most
Fund Call Options
| Name | Net Calls | Calls | Puts |
Return since 31 Dec ‘25 |
|
|---|---|---|---|---|---|
| $61.8M | $143M | $80.7M | 41.5% |
|
|
| $61.8M | $64.6M | $2.79M | 55% |
|
|
| $61.4M | $304M | $243M | 115% |
|
|
454
CRISPR Therapeutics
CRSP
$5.37B
| $61M | $233M | $172M | 4% |
|
| $60.7M | $66M | $5.26M | 53.5% |
|
|
| $60.4M | $60.4M | $0 | 22% |
|
|
| $60.4M | $203M | $143M | 32.1% |
|
|
| $60.3M | $78.8M | $18.6M | 18.6% |
|
|
| $59.9M | $69.6M | $9.78M | 46% |
|
|
| $59.3M | $158M | $99M | 36.1% |
|
|
461
Enovis
ENOV
$1.19B
| $59.3M | $61M | $1.71M | 22.3% |
|
| $59.1M | $83.8M | $24.7M | 17.3% |
|
|
| $59M | $107M | $47.8M | 54.1% |
|
|
| $58.9M | $89.1M | $30.3M | 21% |
|
|
| $57.9M | $212M | $154M | 35.4% |
|
|
| $57.9M | $312M | $254M | 14.3% |
|
|
| $57.7M | $62.7M | $4.99M | 10.8% |
|
|
| $57.7M | $83.5M | $25.8M | 14.4% |
|
|
| $57.4M | $74.9M | $17.5M | 44.6% |
|
|
| $57.4M | $254M | $196M | 51.6% |
|
|
| $57.3M | $64.1M | $6.78M | 168% |
|
|
| $57.2M | $67M | $9.83M | 31.3% |
|
|
| $57.1M | $105M | $47.8M | 5.75% |
|
|
| $57M | $59.1M | $2.08M | 11.7% |
|
|
| $56.8M | $68.1M | $11.2M | 47.4% |
|